Anti-CCP (Cyclic Citrullinated Peptide) Antibodies, IgG and IgA (RDL)

TEST: 520008
Test number copied
CPT: 86200
Print Share

Synonyms

  • Anti-Cyclic Citrullinated Peptide Ab
  • CCP
  • Cyclic Citrullinated Peptide Antibody

Expected Turnaround Time

5 - 7 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

For more information, please view the literature below.

Rheumatoid Arthritis Testing With Better Performance Brochure

Rheumatoid Arthritis: Novel Serologic Markers White Paper

Rheumatoid Arthritis (RA) Comprehensive Testing Brochure

Specimen Requirements

Specimen

Serum

Volume

1 mL

Minimum Volume

0.5 mL (Note: This volume does not allow for repeat testing.)

Container

Red-top tube or gel-barrier tube

Collection

Separate serum from cells within one hour of collection. Transfer to a plastic transport tube before shipping. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.

Storage Instructions

Refrigerate or freeze.

Stability Requirements

Temperature

Period

Room temperature

7 days

Refrigerated

14 days

Frozen

60 days

Freeze/thaw cycles

Stable x1

Causes for Rejection

Grossly hemolyzed; bacterial contamination; lipemic specimen; icteric specimen; non-serum specimen types

Test Details

Use

Anti-CCP (cyclic citrullinated peptide) antibodies are autoantibodies present in established rheumatoid arthritis (RA) (sensitivity 66-79%) and early RA (sensitivity 59%).1,2 In addition, Anti-CCP is more specific than RF diagnosis (specificity 90-96%).1,3

Limitations

This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.

Methodology

Enzyme-linked immunosorbent assay (ELISA)

Footnotes

1. Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis. 2003 Sep;62(9):870-874.12922961
2. Maksymowych WP, Naides SJ, Bykerk V, et al. Serum 14-3-3 eta is a novel marker that complements current serological measurements to enhance detection of patient with rheumatoid arthritis. J Rheumatol. 2014 Nov;41(11):2104-2113.25128504
3. Dubucquoi S, Solau-Gervais E, Lefranc D, et al. Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis. 2004 Apr;63(4):415-419.15020336

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
520008 Anti-CCP Ab, IgG + IgA (RDL) 57093-7 520047 Anti-CCP Ab, IgG + IgA (RDL) Units 57093-7

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf